Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2R,3R,4S,5R,6R)-2-((2S,3R,4R,5S,6R)-2-((2R,3R,4S,5R,6S)-5-(benzoyloxy)-4-(benzyloxy)-2-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoyloxy)methyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3-yloxy)-5-(dihydroxyhydrosulfinyloxy)-6-((dihydroxyhydrosulfinyloxy)methyl)-3-(1,3-dioxoisoindolin-2-yl)tetrahydro-2H-pyran-4-yloxy)-4-(benzyloxy)-5-((2S,3R,4R,5S,6R)-5-(dihydroxyhydrosulfinyloxy)-6-((dihydroxyhydrosulfinyloxy)methyl)-3-(1,3-dioxoisoindolin-2-yl)-4-(4-oxopentanoyloxy)tetrahydro-2H-pyran-2-yloxy)-6-(pivaloyloxymethyl)tetrahydro-2H-pyran-3-yl benzoate
ID: ALA4209610
Max Phase: Preclinical
Molecular Formula: C96H99F17N2O42S4
Molecular Weight: 2404.05
Molecule Type: Unknown
Associated Items: